Assessment of titanium dioxide nanoparticle effects in bacteria: Association, uptake, mutagenicity, co-mutagenicity and DNA repair inhibition

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 768, Issue , 2014, Pages 14-22

  Butler, Kimberly S ^a   Casey, Brendan J ^a   Garborcauskas, Garret V M ^a   Dair, Benita J ^a   Elespuru, Rosalie K ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

Author keywords

Bacterial mutagenesis; EDS; Flow cytometry; Nanoparticle uptake; TEM

Indexed keywords

BACTERIAL DNA; MUTAGENIC AGENT; TITANIUM DIOXIDE NANOPARTICLE; WATER; NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE;

ARTICLE; BACTERIUM MUTANT; CONTROLLED STUDY; DNA REPAIR; DOSE TIME EFFECT RELATION; ELECTRON MICROSCOPY; ESCHERICHIA COLI; EXCISION REPAIR; FLOW CYTOMETRY; LIGHT SCATTERING; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; SALMONELLA TYPHIMURIUM; SENSITIVITY ANALYSIS; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; MUTAGENESIS; MUTATION; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; ULTRASTRUCTURE;

DNA REPAIR; DNA, BACTERIAL; ESCHERICHIA COLI; MUTAGENESIS; MUTATION; NANOPARTICLES; SALMONELLA TYPHIMURIUM; TITANIUM;

EID: 84900327196     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2014.04.008     Document Type: Article

References (27)

1. Doak S.H., Manshian B., Jenkins G.J., Singh N. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. Mutat. Res. 2012, 745:104-111.
2. Chakraborty M., Jain S., Rani V. Nanotechnology: emerging tool for diagnostics and therapeutics. Appl. Biochem. Biotechnol. 2011, 165:1178-1187.
3. Taylor E., Webster T.J. Reducing infections through nanotechnology and nanoparticles. Int. J. Nanomedicine 2011, 6:1463-1473.
4. Galvin P., Thompson D., Ryan K.B., McCarthy A., Moore A.C., Burke C.S., Dyson M., MacCraith B.D., Gun'ko Y.K., Byrne M.T., Volkov Y., Keely C., Keehan E., Howe M., Duffy C., MacLoughlin R. Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications. Cell. Mol. Life Sci. 2012, 69:389-404.
5. Yigit M.V., Moore A., Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. J. Appl. Toxicol. 2012, 29:1180-1188.
6. Szelenyi I. Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases. Inflamm. Res. 2012, 61:1-9.
7. Bhaskar S., Tian F., Stoeger T., Kreyling W., de la Fuente J.M., Grazu V., Borm P., Estrada G., Ntziachristos V., Razansky D. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol. 2010, 7:3.
8. Ai J., Biazar E., Jafarpour M., Montazeri M., Majdi A., Aminifard S., Zafari M., Akbari H.R., Rad H.G. Nanotoxicology and nanoparticle safety in biomedical designs. Int. J. Nanomedicine 2011, 6:1117-1127.
9. Warheit D.B., Donner M. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines. Nanotoxicology 2010, 4:409-413.
10. Landsiedel R., Kapp M.D., Schulz M., Wiench K., Oesch F. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test materials, potential artifacts and limitations - many questions, some answers. Mutat. Res. 2009, 681:241-258.
11. Ng C.T., Li J.J., Bay B.H., Yung L.L. Current studies into the genotoxic effects of nanomaterials. J. Nucleic Acids 2010, 2010:12. Article ID 947859.
12. Kumar A., Pandey A.K., Signh S.S., Shanker R., Dhawan A. Cellular uptake and mutagenic potential of metal oxide nanoparticles. Chemosphere 2011, 83:1124-1132.
13. Nohynek G.J., Ladenamm J., Ribaud C., Roberts M.S. Grey Goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit. Rev. Toxicol. 2007, 37:251-277.
14. Weir A., Westerhoff P., Fabricius L., Hristovski K., von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 2012, 46:2242-2250.
15. Landsiedel R., Ma-Hock L., van Ravenzwaay B., Schulz M., Wiench K., Champ S., Schulte S., Wohlleben W., Oesch F. Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UV-protection in cosmetic formulations. Nanotoxicology 2010, 4:364-381.
16. Nakagawa Y., Wakuri S., Sakamoto K., Tanaka N. The photogenotoxicity of titanium dioxide particles. Mutat. Res. 1997, 394:125-132.
17. Pan X., Redding J.E., Wiley P.A., Wen L., McConnell J.S., Zhang B. Mutagenicity evaluation of metal oxide nanoparticles by the bacterial reverse mutation assay. Chemosphere 2010, 79:113-116.
18. Woodruff R.S., Li Y., Yan J., Bishop M., Jones M.Y., Watanabe F., Biris A.S., Rice P., Zhou T., Chen T. Genotoxicity evaluation of titanium dioxide nanoparticles using the Ames test and Comet assay. J. Appl. Toxicol. 2012, 32:934-943.
19. Lopes I., Ribeiro R., Antunes F.E., Rocha-Santos T.A.P., Rasteiro M.G., Soares A.M.V.M., Goncalves F., Pereira R. Toxicity and genotoxicity of organic and inorganic nanoparticles to the bacteria Vibro fischeri and Salmonella typhimurium. Ecotoxicology 2012, 21:637-648.
20. Patri A., Umbreit T., Zheng J., Nagashima K., Goering P., Francke-Carroll S., Gordon E., Weaver J., Miller T., Sadrieh N., McNeil S., Stratmeyer M. Energy dispersive X-ray analysis of titanium dioxide nanoparticle distribution after intravenous and subcutaneous injection in mice. Journal of Applied Toxicology 2009, 29:662-672.
21. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
22. Donaldson K., Poland C., Schins R. Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies. Nanotoxicology 2010, 4:414-420.
23. Kang S.J., Young J.L., Kim B.M., Choi Y.J., Chung H.W. Cytotoxicity and genotoxicity of titanium dioxide nanoparticles in UVA-irradiated normal perifpheral blood lymphocytes. Drug Chem. Toxicol. 2011, 34:277-284.
24. Shi Y., Zhang J.H., Jiang M., Zhu L.H., Tan H.Q., Lu B. Synergistic genotoxicity caused by low concentration of titanium dioxide nanoparticles and p,p'-DDT in human hepatocytes. Environ. Mol. Mutagen. 2010, 51:192-204.
25. Barrán-Berdón A.L., Pozzi D., Caracciolo G., Capriotti A.L., Caruso G., Cavaliere C., Riccioli A., Palchetti S., Laganà A. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. Langmuir 2013, 29:6485-6494.
26. Saptarshi S.R., Duschl A., Lopata A.L. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J. Nanobiotechnol. 2013, 11:26.
27. Tenzer S., Docter D., Kuharev J., Musyanovych A., Fetz V., Hecht R., Schlenk F., Fischer D., Kiouptsi K., Reinhardt C., Landfester K., Schild H., Maskos M., Knauer S.K., Stauber R.H. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol. 2013, 8:772-781.